Variables associated with nonadherence in clinically stable patients with bipolar disorder;Variables asociadas a la no adherencia en pacientes con trastorno bipolar en estabilidad clínica

Actas Espanolas de Psiquiatria

Volumn 44, Issue 5, 2016, Pages 157-165

  Navarro, Santiago ^a   Rodríguez, Fernando ^a   Acosta, Francisco J ^b,c   García Bello, Miguel ^a  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^b Programa de Investigación en Salud Mental de Canarias   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Beliefs; Bipolar disorder; Clinical stability; Medication adherence; Risk factors

Indexed keywords

BIPOLAR DISORDER; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84991253297     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97.
2. Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70(Suppl 4) 1-46; quiz 47-8.
3. Leclerc E, Mansur RB, Brietzke E. Determinants of adherence to treatment in bipolar disorder: a comprehensive review. J Affect Disord. 2013;149(1-3):247-52.
4. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002;105(3):164-72.
5. Simhandl C, König B, Amann BL. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J Clin Psychiatry. 2014;75(3):254-62; quiz 263.
6. Gónzalez-Pinto A, Mosquera F, Alonso M, López P, Ramírez F, Vieta E, et al. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord. 2006;8:618-24.
7. Adams J, Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand. 2000;101:119-24.
8. Eaddy M, Grogg A, Locklear J. Assessment of compliance with antipsyshotic treatment and resource utilization in a Medicaid population. Clin Ther. 2005;27:263-72.
9. Colom F, Vieta E, Martínez-Arán A, Reinares M, Benabarre A, Gastó C. Clinical factors associated to treatment no compliance in euthymic bipolar patients. J Clinic Psychiatry. 2000;61:549-54.
10. Svarstad BL, Shiermana TI, Sweeney JK, Using Drug claims data to asses the relationship of medication adherence with hospitalisation and costs. Psychiatr Serv. 2001;52:805-11.
11. Jónsdóttir H, Opjordsmoen S, Birkenaes AB, Simonsen C, Engh JA, Ringen PA, et al. Predictors of medication adherence in patients with schizophrenia and bipolar disorder. Acta Psychiatr Scand. 2013;127(1):23-33.
12. Yen CF, Chen CS, Ko CH, Yeh ML, Yang SJ, Yen JY, et al. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: Prospective study. Psychiatry Clin Neurosci. 2005;59:403-9.
13. Hou R, Cleak V, Peveler R. Do treatment and illness beliefs influence adherence to medication in patients with bipolar affective disorder? A preliminary cross-sectional study. Eur Psychiatry. 2010;25(4):216-9.
14. Sajatovic M, Ignacio RV, West JA, Cassidy KA, Safavi R, Kilbourne AM, et al. Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Compr Psychiatry. 2009;50(2):100-7.
15. Pompili M, Venturini P, Palermo M, Stefani H, Seretti ME, Lamis DA, et al. Mood disorders medications: predictors of nonadherence - review of the current literature. Expert Rev Neurother. 2013;13(7):809-25.
16. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. Assessment of insight in Psychosis. Am J Psychiatry. 1993;150:873-9.
17. Ruiz A, Pousa E, Duñó R, Crosas J, Cuppa S, García C. Spanish adaptation of the Scale to Asses Unawareness of Mental Disorder (SUMD). Actas Esp Psiquiatr. 2008;36(2):111-9.
18. Hogan TP, Awad AG, Eastwood MR. A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychol Med. 1983;13:177-83.
19. Sajatovic M, Velligan DI, Weiden PJ, Valenstein MA, Ogedegbe G. Measurement of psychiatric treatment adherence. J Psychosom Res. 2010;69(6):591-9.
20. Robles García R, Salazar Alvarado V, Páez Agraz F, Ramírez Barreto F. Assessment of drug attitudes in patients with schizophrenia: psychometric properties of the DAI Spanish version. Actas Esp Psiquiatr. 2004;32(3):138-42.
21. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health. 1999;14:1-24.
22. Beléndez-Vázquez M, Hernández-Mijares A, Horne R, Weinman J. Evaluación de las creencias sobre el tratamiento: validez y fiabilidad de la versión española del Beliefs about Medicines Questionnaire. Int J Clin Hlth Psyc. 2007;7(3):767-79.
23. Rosa AR, Sánchez-Moreno J, Martinez-Aran A, Salamero M, Torrent C, Reinares M, et al. Validity and Reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3:5.
24. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997;73(3):159-71.
25. Vieta Pascual E, Torrent Font C, Martínez-Arán A, Colom Victoriano F, Reinares Gabnepen M, Benabarre Hernández A, et al. A user-friendly scale for the short and long term outcome of bipolar disorder: the CGI-BP-M. Actas Esp Psiquiatr. 2002;30(5):301-4.
26. Vieta E, De Arce R, Jiménez-Arriero MA, Rodriguez A, Balanzá V, Cobaleda S. Detection of subclinical depression in bipolar disorder: a cross-sectional, 4-month prospective follow-up study at community mental health services (SIN-DEPRES). J Clin Psychiatry. 2010;71(11):1465-74.
27. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
28. Val A, Amorós G, Martínez P, Ferández ML, León M. Estudio descriptivo del cumplimiento del tratamiento farmacológico antihipertensivo y validación del test Morisky y Green. Aten Primaria. 1992;10:767-70.
29. Montes JM, Maurino J, De Dios C, Medina E. Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning. Patient Prefer Adherence. 2013;7:89-94.
30. Teter CJ, Falone AE, Bakaian AM, Tu C, Ongür D, Weiss RD. Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder. Psychiatry Res. 2011;190(2-3):253-8.
31. Gaudiano BA, Weinstock LM, Miller IW. Improving treatment adherence in patients with bipolar disorder and substance abuse: rationale and initial development of a novel psychosocial approach. J Psychiatr Pract. 2011;17(1):5-20.
32. Laakso LJ. Motivational interviewing: addressing ambivalence to improve medication adherence in patients with bipolar disorder. Issues Ment Health Nurs. 2012;33(1):8-14.
33. González-Pinto A, Reed C, Novick D, Bertsch J, Haro JM. Assessment of medication adherence in a cohort of patients with bipolar disorder. Pharmacopsychiatry. 2010;43(7):263-70.
34. Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol. 2008;23(2):95-105.
35. Látalová K. Insight in bipolar disorder. Psychiatr Q. 2012;83(3):293-310.
36. Furniss D, Barber N, Lyons I, Eliasson L, Blandford A. Unintentional non-adherence: can a spoon full of resilience help the medicine go down? BMJ Qual Saf. 2014;23(2):95-8.
37. Clatworthy J, Bowskill R, Parham R, Rank T, Scott J, Horne R. Understanding medication non-adherence in bipolar disorders using a Necessity-Concerns Framework. J Affect Disord. 2009;116(1-2):51-5.
38. Sajatovic M, Levin J, Fuentes-Casiano E, Cassidy KA, Tatsuoka C, Jenkins JH. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication. Compr Psychiatry. 2011;52(3):280-7.
39. Julius RJ, Novitsky MA Jr, Dubin WR. Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract. 2009;15(1):34-44.
40. Morselli PL, Elgie R; GAMIAN-Europe. GAMIAN-Europe/BEAM survey I-global analysis of a patient questionnaire circulated to 3450 members of 12 European advocacy groups operating in the field of mood disorders. Bipolar Disord. 2003;5(4):265-78.
41. Solomon DA, Ristow WR, Keller MB, Kane JM, Gelenberg AJ, Rosenbaum JF, et al. Serum lithium levels and psychosocial function in patients with bipolar I disorder. Am J Psychiatry. 1996;153:1301-7.
42. Sanchez-Moreno J, Martinez-Aran A, Tabarés-Seisdedos R, Torrent C, Vieta E, Ayuso-Mateos JL. Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom. 2009;78(5):285-97.
43. Martínez-Arán A, Scott J, Colom F, Torrent C, Tabares-Seisdedos R, Daban C, et al. Treatment nonadherence and neurocognitive impairment in bipolar disorder. J Clin Psychiatry. 2009;70(7):1017-23.